Qube Research & Technologies (QRT)
AEMD icon

Qube Research & Technologies (QRT)’s Aethlon Medical AEMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14
Closed -$549 – 3234
2024
Q2 		$549 Buy
+14
New +$1.1K ﹤0.01% 3308

Other funds holding AEMD

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AEMD Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Aethlon Medical (AEMD) in Q3 2024, closing a stake of 14 shares — an estimated $549 sold.

Qube Research & Technologies (QRT) first reported a position in AEMD in Q2 2024 and held it in 1 quarter. The position peaked at $549 in Q2 2024. 15 funds tracked by Wall St. Rank hold AEMD as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Aethlon Medical position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 14 Aethlon Medical shares in Q3 2024, an estimated $549.
  • Qube Research & Technologies (QRT) first reported a position in Aethlon Medical in Q2 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Aethlon Medical position peaked at $549 in Q2 2024.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.